Amoy Diagnostics board approves governance changes, share capital adjustment

Amoy Diagnostics (SZSE:300685) convened its Tenth Meeting of the Fourth Session of the Board of Directors on December 9, 2025, approving numerous revisions to its corporate governance documents. Key resolutions include amendments to the Articles of Association, Shareholder Meeting Rules, Board of Directors Meeting Rules, and various internal control policies. The company also decided to eliminate the supervisory board, with the audit committee assuming its responsibilities, and to integrate a worker representative director into the board.

Concurrently, the company's registered capital and share capital will be adjusted from CNY 393,061,969 to CNY 391,536,144 due to completed restricted share repurchases and cancellations. These changes, aimed at aligning with the new "Company Law" and enhancing governance, require approval at the Second Interim Shareholders' Meeting of 2025, scheduled for December 25, 2025.

The supervisory board also held its Eighth Meeting of the Fourth Session on December 9, 2025, approving the Articles of Association revisions and the abolition of the Supervisory Board Meeting Rules, both of which will be put to a shareholder vote. Shareholders can participate in the meeting via in-person and online voting through the Shenzhen Stock Exchange systems.